Background Polyclonal convalescent plasma may be obtained from donors who have
recovered from coronavirus disease 2019 (Covid-19). The efficacy of this plasma in preventing …

Many trauma centers use mainly physiologic, first‐tier criteria and mechanism‐related,
second‐tier criteria to determine whether and at what level to activate a multidisciplinary trauma …

BACKGROUND: The efficacy of polyclonal high titer convalescent plasma to prevent
serious complications of COVID-19 in outpatients with recent onset of illness is uncertain. …

Dental emergencies are common problems seen in the emergency department (ED).
Approximately 750,000 visits are made to EDs annually for dental problems. 1, 2 Pain, trauma, and …

BACKGROUND: The efficacy of SARS-CoV-2 convalescent plasma (CCP) for preventing
infection in exposed, uninfected individuals is unknown. CCP might prevent infection when …

Background The efficacy of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
convalescent plasma (CCP) for preventing infection in exposed, uninfected individuals is …

BACKGROUND: The efficacy of SARS-CoV-2 convalescent plasma (CCP) for preventing
infection in exposed, uninfected individuals is unknown. We hypothesized that CCP might …

Background COVID‐19 convalescent plasma (CCP) is an important therapeutic option for
outpatients at high risk of hospitalization from SARS‐CoV‐2 infection. We assessed the safety …

Septic arthritis of the acromioclavicular (AC) joint is a rare but rapidly destructive etiology of
acute shoulder pain. We report a case of septic AC joint in the absence of trauma or …

SARS-CoV-2 antibody levels associated with reduced hospitalization risk remain undefined.
Our outpatient COVID-19 convalescent plasma (CCP), placebo-controlled trial observed …